Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms

(2010) Francesco Angelucci et al.   ADDICTION BIOLOGY

Synaptic Activity Controls Dendritic Spine Morphology by Modulating eEF2-Dependent BDNF Synthesis

(2010) C. Verpelli et al.   JOURNAL OF NEUROSCIENCE

Antiapoptotic and neurotrophic effects of antidepressants: A review of clinical and experimental studies

(2009) Łukasz R. Drzyzga et al.   BRAIN RESEARCH BULLETIN

Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients

(2009) Gislaine S. de Oliveira et al.   JOURNAL OF PSYCHIATRIC RESEARCH

TrkB signalling pathways in LTP and learning

(2009) Liliana Minichiello   NATURE REVIEWS NEUROSCIENCE

Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers

(2008) Francesco Angelucci et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Expression of mRNA of Neurotrophic Factors and their Receptors are Significantly Altered After Subchronic Ketamine Treatment

(2008) Axel Becker et al.   Medicinal Chemistry

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

(2007) Lêda S.B. Garcia et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY